ZAI LAB announced a strategic partnership with MediLink Therapeutics to jointly develop a novel LRRC15 antibody-drug conjugate.
- Latest
- Detail
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
14:35
Ubisoft has hired consultants to review its transformation strategy.
.DJI+0.25%
14:35
J.P. Morgan: Maintains CATHAY PAC AIR "Shareholding" rating, Target Price is raised to 12.3 HKD.
CATHAY PAC AIR-1.32%
14:33
Japanese stocks closed: the Nikkei 225 Index fell by 1.05%, Fast Retailing dropped more than 6%.
Nikkei 225-0.90%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.